Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma
Sergio Giralt, Laurent Garderet, Brian G.M. Durie, Gordon Cook, Gösta Gahrton, Benedetto Bruno, Parameswaran Hari, Henk M. Lokhorst, Phillip McCarthy, Amrita Krishnan, Pieter Sonneveld, H. Goldschmidt, Sundar Jagannath, Bart Barlogie, María‐Victoria Mateos, Peter Gimsing, Orhan Sezer, Joseph Mıkhael, Jin Lu, Meletios A Dimopoulos, Amitabha Mazumder, Antonio Palumbo, Rafat Abonour, Kenneth C. Anderson, Michel Attal, Joan Bladé, Jenny Bird, Michèle Cavo, Raymond L. Comenzo, Javier de la Rubia, Hermann Einsele, Ramón García‐Sánz, Jens Hillengaß, Sarah A. Holstein, Hans Erik Johnsen, Douglas Joshua, Guenther Koehne, Shaji Kumar, Robert A. Kyle, Xavier Leleu, Sagar Lonial, Heinz Ludwig, Hareth Nahi, A K Nooka, Robert Z. Orlowski, S. Vincent Rajkumar, Tony Reiman, Paul Richardson, Eloísa Riva, Jesús F. San Miguel, Ingemar Turreson, Saad Z. Usmani, David H. Vesole, William Bensinger, Muzaffer Qazilbash, Yvonne A. Efebera, Mohamad Mohty, Christina Gasparreto, James Gajewski, Charles F. LeMaistre, Christopher Bredeson, Philippe Moreau, Marcelo C. Pasquini, Nicolaus Kroeger, Edward A. Stadtmauer (2015). American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma. , 21(12), DOI: https://doi.org/10.1016/j.bbmt.2015.09.016.
Article36 days agoThe efficacy and safety of lenalidomide plus dexamethasone in relapsed and/or refractory multiple myeloma patients with impaired renal function
Meletios A Dimopoulos, Adrían Alegre, Edward A. Stadtmauer, Hartmut Goldschmidt, Jeffrey A. Zonder, Carlos M. de Castro, Zvenyslava Masliak, Donna Reece, Marta Olesnyckyj, Zhinuan Yu, Donna M. Weber (2010). The efficacy and safety of lenalidomide plus dexamethasone in relapsed and/or refractory multiple myeloma patients with impaired renal function. , 116(16), DOI: https://doi.org/10.1002/cncr.25139.
Article36 days agoEffects of Lenalidomide and Dexamethasone Treatment Duration on Survival in Patients With Relapsed or Refractory Multiple Myeloma Treated With Lenalidomide and Dexamethasone
Jesús F. San Miguel, Meletios A Dimopoulos, Edward A. Stadtmauer, S. Vincent Rajkumar, David S. Siegel, M. L. Casadebaig Bravo, Marta Olesnyckyj, Robert Knight, Jerome B. Zeldis, Jean‐Luc Harousseau, Donna M. Weber (2010). Effects of Lenalidomide and Dexamethasone Treatment Duration on Survival in Patients With Relapsed or Refractory Multiple Myeloma Treated With Lenalidomide and Dexamethasone. , 11(1), DOI: https://doi.org/10.3816/clml.2010.n.120.
Article36 days agoLonger Duration of Treatment and Maintenance of Best Response with Lenalidomide and Dexamethasone Prolongs Overall Survival in Patients with Relapsed or Refractory Multiple Myeloma
Jesús F. San Miguel, Meletios A Dimopoulos, Edward A. Stadtmauer, S. Vincent Rajkumar, David S. Siegel, Marie‐Laure Casadebaig Bravo, Marta Olesnyckyj, Robert Knight, Jerome B. Zeldis, Jean‐Luc Harousseau, Donna M. Weber (2008). Longer Duration of Treatment and Maintenance of Best Response with Lenalidomide and Dexamethasone Prolongs Overall Survival in Patients with Relapsed or Refractory Multiple Myeloma. , 112(11), DOI: https://doi.org/10.1182/blood.v112.11.3702.3702.
Article36 days agoLenalidomide Plus High-Dose Dexamethasone Provides Improved Overall Survival Compared to High-Dose Dexamethasone Alone for Relapsed or Refractory Multiple Myeloma (MM): Results of 2 Phase III Studies (MM-009, MM-010) and Subgroup Analysis of Patients with Impaired Renal Function.
Donna Weber, Michael Wang, Christine Chen, Andrew R. Belch, Edward A. Stadtmauer, Ruben Niesvisky, Zhinuan Yu, Marta Olesnyckyj, Jerome B. Zeldis, Robert Knight, Meletios A Dimopoulos (2006). Lenalidomide Plus High-Dose Dexamethasone Provides Improved Overall Survival Compared to High-Dose Dexamethasone Alone for Relapsed or Refractory Multiple Myeloma (MM): Results of 2 Phase III Studies (MM-009, MM-010) and Subgroup Analysis of Patients with Impaired Renal Function.. , 108(11), DOI: https://doi.org/10.1182/blood.v108.11.3547.3547.
Article36 days ago